コーパス検索結果 ( left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 Blocking or depletion of Kupffer cells, an approach for the treatment of liver diseases, has shown contr
2 s leading to the formation of MFBs represents an attractive approach for the treatment of diverse fibrosis-related diseas
3 Second, we describe our management-based approach for the treatment of infective endocarditis, leading
4 es the efficacy of non-viral TUS-based hSef-b gene delivery approach for the treatment of prostate cancer tumors, and pos
5 signaling may constitute an attractive novel and double-hit approach for the treatment of atherosclerosis.
6 nt Treg cells might represent a promising immunotherapeutic approach for the treatment of breast cancer.
8 Transoral endoscopic head and neck surgery is a new approach for the treatment of oropharyngeal tumors.
9 in type 8 (TRPM8) is currently under investigation as a new approach for the treatment of pain and other diseases.
10 (mAChR) via a positive allosteric modulator (PAM) is a new approach for the treatment of the cognitive impairments assoc
11 This immunotherapy may be an interesting new approach for the treatment of chronic viral infections.
12 l that therapeutic lymphangiogenesis may be a promising new approach for the treatment of cardiovascular diseases.
13 findings suggest that KMO inhibition may be a promising new approach for the treatment of nicotine addiction.
14 randomized trial might help to clarify the role of this new approach for the treatment of early HCC.
15 rvations suggest that CRF antagonists may represent a novel approach for the treatment of ADHD and other disorders associ
16 IL-1 pathway in tumor microenvironments may provide a novel approach for the treatment of cancer.
17 as a lead CcO inhibitor for further optimization as a novel approach for the treatment of glioblastoma and related cancer
20 e model and support a role for selective M1 PAMs as a novel approach for the treatment of schizophrenia.
21 Furthermore, this study identifies a novel approach for the treatment of tumors resistant to traditional
22 rbable vascular scaffolds (BVS) represent a promising novel approach for the treatment of coronary artery disease.
23 nism of CB2 receptors may represent a novel pharmacological approach for the treatment of allergic inflammation and other
27 (+)Foxp3(+) regulatory T (Treg) cell therapy is a promising approach for the treatment of autoimmune diseases.
28 lockade of metallothioneins 1 and 2 constitutes a promising approach for the treatment of conditions which result in musc
29 g of tumor cells using bispecific antibodies is a promising approach for the treatment of hematologic malignancies.
30 st that CBS enzyme replacement therapy (ERT) is a promising approach for the treatment of homocystinuria and that ERT for
31 cyclic peptides as structural backbones offers a promising approach for the treatment of IBD and potentially other chron
32 A nanoparticle-mediated siRNA delivery could be a promising approach for the treatment of intestinal inflammation.
33 cell properties within tumours may be a clinically relevant approach for the treatment of colorectal tumours.
34 with aerobic biodegradation may be a promising synergistic approach for the treatment of mixed contaminants.
35 The inhibition of PORCN could serve as a therapeutic approach for the treatment of a number of Wnt-dependent cance
37 LC2 activation and implicate their utility as a therapeutic approach for the treatment of ILC2-mediated allergic asthma a
38 otic skin with omega-O-acylceramides might be a therapeutic approach for the treatment of skin symptoms in individuals af
39 EMENT In this work, we paved the road for a new therapeutic approach for the treatment of brain tumors, demonstrating the
40 These findings suggest a new therapeutic approach for the treatment of progressive forms of multiple s
41 yndromes and so could therefore provide a novel therapeutic approach for the treatment of anaemia associated with lower-r
43 Inhibition of miR-125b may represent a novel therapeutic approach for the treatment of human cardiac fibrosis and othe
44 f adenosine A1 receptors (A1ARs) offers a novel therapeutic approach for the treatment of numerous central and peripheral
46 le oncogenic signaling proteins, is a promising therapeutic approach for the treatment of cancers.
47 /2 to prevent H3K9 methylation loss is a viable therapeutic approach for the treatment of heart disease.
49 Targeting CRABP2 overexpression may represent a unique approach for the treatment of human MPNSTs.
50 ort the further development of this multifunctional vaccine approach for the treatment of synucleinopathies, such as Park
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。